Article info

Download PDFPDF

Extended report
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Authors

  1. Correspondence to Dr Michael Schiff, University of Colorado, School of Medicine, 5400 South Monaco Street, Greenwood Village, CO 80111, USA; michael.schiff{at}me.com
View Full Text

Citation

Schiff M, Weinblatt ME, Valente R, et al
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial

Publication history

  • Received April 26, 2013
  • Revised July 29, 2013
  • Accepted July 29, 2013
  • First published August 20, 2013.
Online issue publication 
December 04, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.